AAAAAA

   
Results: 1-8 |
Results: 8
PREVENTION OF VASCULAR THROMBOSIS IN DOGS BY THE ACTIVE METABOLITE OFORBOFIBAN
Authors: SZALONY JA TAITE BB FREDERICK LG SULEYMANOV OD KING LW SALYERS AK NICHOLSON NS
Citation: Ja. Szalony et al., PREVENTION OF VASCULAR THROMBOSIS IN DOGS BY THE ACTIVE METABOLITE OFORBOFIBAN, The FASEB journal, 12(5), 1998, pp. 4175-4175
PROTECTIVE EFFECT OF ORAL XEMILOFIBAN IN ARTERIAL THROMBOSIS IN DOGS - INCREASED ACTIVITY IN COMBINATION WITH ASPIRIN
Authors: FREDERICK LG SULEYMANOV OD SZALONY JA TAITE BB SALYERS AK KING LW FEIGEN LP NICHOLSON NS
Citation: Lg. Frederick et al., PROTECTIVE EFFECT OF ORAL XEMILOFIBAN IN ARTERIAL THROMBOSIS IN DOGS - INCREASED ACTIVITY IN COMBINATION WITH ASPIRIN, Circulation, 98(8), 1998, pp. 813-820
EFFECTS OF SC-52458, AN ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST, IN THEDOG
Authors: MCMAHON EG YANG PC BABLER MA SULEYMANOV OD PALOMO MA OLINS GM COOK CS
Citation: Eg. Mcmahon et al., EFFECTS OF SC-52458, AN ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST, IN THEDOG, American journal of hypertension, 10(6), 1997, pp. 671-677
THE PROTECTIVE DOSE OF THE POTENT GPIIB IIIA ANTAGONIST SC-54701A IS REDUCED WHEN USED IN COMBINATION WITH ASPIRIN AND HEPARIN IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS/
Authors: FREDERICK LG SULEYMANOV OD KING LW SALYERS AK NICHOLSON NS FEIGEN LP
Citation: Lg. Frederick et al., THE PROTECTIVE DOSE OF THE POTENT GPIIB IIIA ANTAGONIST SC-54701A IS REDUCED WHEN USED IN COMBINATION WITH ASPIRIN AND HEPARIN IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS/, Circulation, 93(1), 1996, pp. 129-134
ANTITHROMBOTIC EFFECTS OF SC-54701A (SCA) IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS
Authors: FREDERICK LG SULEYMANOV OD KING LW SALYERS AK NICHOLSON NS FEIGEN LP
Citation: Lg. Frederick et al., ANTITHROMBOTIC EFFECTS OF SC-54701A (SCA) IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS, The FASEB journal, 9(3), 1995, pp. 55-55
ASPIRIN LOWERS THE EFFECTIVE DOSE OF A GP IIB IIIA ANTAGONIST IN A DOG-MODEL OF CORONARY-THROMBOSIS/
Authors: FEIGEN LP FREDERICK LG KING LW SULEYMANOV OD NICHOLSON NS
Citation: Lp. Feigen et al., ASPIRIN LOWERS THE EFFECTIVE DOSE OF A GP IIB IIIA ANTAGONIST IN A DOG-MODEL OF CORONARY-THROMBOSIS/, Thrombosis and haemostasis, 73(6), 1995, pp. 1333-1333
EFFECTS OF SC-56525, A POTENT, ORALLY-ACTIVE RENIN INHIBITOR, IN SALT-DEPLETED AND RENAL HYPERTENSIVE DOGS
Authors: MCMAHON EG YANG PC BABLER MA BITTNER SE SULEYMANOV OD CAINJANICKI KJ BEDELL LJ HANSON GJ COOK CS
Citation: Eg. Mcmahon et al., EFFECTS OF SC-56525, A POTENT, ORALLY-ACTIVE RENIN INHIBITOR, IN SALT-DEPLETED AND RENAL HYPERTENSIVE DOGS, Hypertension, 26(1), 1995, pp. 95-100
BLOCKADE OF ANGIOTENSIN-II PRESSOR-RESPONSES AND ANTIHYPERTENSIVE ACTIVITY OF SC-52458 (AT1 RECEPTOR ANTAGONIST) IN DOG
Authors: MCMAHON EG PALOMO MA OLINS GM BITTNER SE BABLER MA YANG PC SULEYMANOV OD BARATTA M KOSOBUD LA MILLER KJ COOK CS
Citation: Eg. Mcmahon et al., BLOCKADE OF ANGIOTENSIN-II PRESSOR-RESPONSES AND ANTIHYPERTENSIVE ACTIVITY OF SC-52458 (AT1 RECEPTOR ANTAGONIST) IN DOG, The FASEB journal, 8(4), 1994, pp. 10000329-10000329
Risultati: 1-8 |